CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or CL.
Correlation
The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. CL - Performance Comparison
Key characteristics
CPRX:
1.53
CL:
0.42
CPRX:
2.49
CL:
0.67
CPRX:
1.28
CL:
1.09
CPRX:
1.78
CL:
0.34
CPRX:
8.94
CL:
0.75
CPRX:
6.96%
CL:
9.22%
CPRX:
40.60%
CL:
16.50%
CPRX:
-94.25%
CL:
-58.91%
CPRX:
-5.97%
CL:
-18.77%
Fundamentals
CPRX:
$2.69B
CL:
$70.94B
CPRX:
$1.18
CL:
$3.51
CPRX:
19.09
CL:
24.91
CPRX:
0.00
CL:
2.01
CPRX:
$349.91M
CL:
$20.10B
CPRX:
$293.37M
CL:
$12.16B
CPRX:
$141.71M
CL:
$4.96B
Returns By Period
In the year-to-date period, CPRX achieves a 7.95% return, which is significantly higher than CL's -3.29% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 20.87%, while CL has yielded a comparatively lower 4.64% annualized return.
CPRX
7.95%
-1.10%
10.06%
63.38%
34.18%
20.87%
CL
-3.29%
-0.87%
-14.61%
5.57%
5.22%
4.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. CL — Risk-Adjusted Performance Rank
CPRX
CL
CPRX vs. CL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.29%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.29% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -58.91%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 8.33% compared to Colgate-Palmolive Company (CL) at 7.63%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities